Will there be a third consecutive forecast upgrade?
The defensive business model combined with growth prospects in the healthcare sector makes the stock interesting!
The broad range of medications could also lead to surprises in Q3!
Reading Time: 1 minute
Currently, defensive stocks are once again in favor with investors. Especially when companies can positively surprise with their fundamentals, harmonious upward movements can develop. In this context, H. Lundbeck A/S might be worth a look again. The pharmaceutical company offers treatments for depression, schizophrenia, Alzheimer's, Parkinson's, migraines, and epilepsy. In May, we already reported on the strong numbers for Q1 in combination with the raised forecast. In August, there was also a convincing half-year report with another forecast upgrade....
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
